Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06240325 · ClinicalTrials.gov registry record · NA

Sleep Promotion Program Primary Care

A NA study of Sleep and Sleep Disturbance, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06240325: Recruiting NA study of Sleep and Sleep Disturbance, sponsored by University of Pittsburgh.

NCT06240325 is a NA study of Sleep and Sleep Disturbance that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 100 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06240325, a NA study of Sleep and Sleep Disturbance, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Investigators developed a brief, scalable, behavioral Sleep Promotion Program (SPP) for adolescents with short sleep duration and sleep-wake irregularity, which relies on two individual sessions and smart phone technology to deliver evidence-based strategies. This R34 will test the feasibility and initial effectiveness of the SPP program and provider training via pilot randomized controlled trial (RCT, n=50) comparing SPP to Sleep Psychoeducation, a brief session on healthy sleep habits. Participants will be adolescents (12-18 years) with short sleep duration, sleep-wake irregularity, and depression.

Primary Outcome

The Feasibility of Intervention Measure (FIM) is a 4-item measure that assesses the feasibility of the intervention, each item is scored on a 1-5 likert scale (completely disagree to completely agree). Items can be evaluated individually or a scale can be created by averaging responses. Scale values range from 1-5.

Interventions

  • BEHAVIORAL SPP
  • BEHAVIORAL Sleep Psychoeducation

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-12-13
Est. Completion 2026-08
Phase NA
University of Pittsburgh

1,238 total trials

What NCT06240325 shows while recruiting

NCT06240325 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which SPP is the first listed.

NCT06240325 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06240325 about?

NCT06240325 is a clinical study titled "Sleep Promotion Program Primary Care". Investigators developed a brief, scalable, behavioral Sleep Promotion Program (SPP) for adolescents with short sleep duration and sleep-wake irregularity, which relies on two individual sessions and smart phone technology to deliver evidence-based strategies. This R34 will test the feasibility and i...

What is the current status of trial NCT06240325?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-12-13. Estimated completion is 2026-08.

What conditions does trial NCT06240325 study?

This clinical trial studies the following conditions: Sleep, Sleep Disturbance, Insufficient Sleep.

What interventions are being tested in trial NCT06240325?

The interventions under investigation include: SPP (BEHAVIORAL), Sleep Psychoeducation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06240325?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06240325 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06240325's enrollment target sits among peer trials

100 59th of 151 higher than 84 of 151 other Sleep trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06240325, the US trial registry maintained by the National Library of Medicine. NCT06240325 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.